The Life Sciences and Pharmaceutical industry is facing momentous challenges. A number of popular drugs are going off patent. On the other hand, the number of new product launches has fallen considerably. Augmented competition, diminutive market successions and greater customer expectations create unparalleled hassles on the life sciences industry's ability to deliver higher value to shareholders and innovative healthcare to patients. Companies are insistent on stepping up their internal R&D productivity, and are concentrating more on reducing expenses, especially in business practices not directly related to R&D or sales and marketing, such as procurement, supply chain and manufacturing. Increasing regulatory pressures are compressing the time available to market a drug and recover the huge investments involved. Side by side, the global demand for drugs is constantly rising.
To meet global rising demand of drugs, we can help improve your clinical decision making with our life sciences' clinical data specialists.
- Protocol Development
- Statistical Analysis Plan
- CDISC Services (SDTM and ADaM)
- SAS Programming
- New Drug Application